Factors that contribute to long-term survival in patients with leukemia not in remission at allogeneic hematopoietic cell transplantation

Journal of Experimental and Clinical Cancer Research

Volumn 30, Issue 1, 2011, Pages

  Koh, Hideo ^a   Nakamae, Hirohisa ^a   Hagihara, Kiyoyuki ^a   Nakane, Takahiko ^a   Manabe, Masahiro ^a   Hayashi, Yoshiki ^a   Nishimoto, Mitsutaka ^a   Umemoto, Yukari ^a   Nakamae, Mika ^a   Hirose, Asao ^a   Inoue, Eri ^a   Inoue, Atsushi ^a   Yoshida, Masahiro ^a   Bingo, Masato ^a   Okamura, Hiroshi ^a   Aimoto, Ran ^a   Aimoto, Mizuki ^a   Terada, Yoshiki ^a   Koh, Ki Ryang ^a   Yamane, Takahisa ^a   Ohsawa, Masahiko ^a   Hino, Masayuki ^a   more..

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CLADRIBINE; CYCLOSPORIN A; FLUDARABINE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ADOLESCENT; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BLAST CELL; BONE MARROW; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER RISK; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CYTOGENETICS; ENGRAFTMENT; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LEUKEMIA; LONG TERM CARE; MALE; MYELODYSPLASTIC SYNDROME; PLASMA CELL LEUKEMIA; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL RATE; ACUTE LYMPHOBLASTIC LEUKEMIA; ALLOTRANSPLANTATION; DISEASE FREE SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; RECURRENT DISEASE;

ADOLESCENT; ADULT; AGED; DISEASE-FREE SURVIVAL; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; KAPLAN-MEIER ESTIMATE; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; LEUKEMIA, MYELOID, ACUTE; LEUKEMIA, PLASMA CELL; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYELODYSPLASTIC SYNDROMES; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RECURRENCE; RETROSPECTIVE STUDIES; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 79953741620     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-30-36     Document Type: Article

References (17)

1. Acute myelogenous leukemia: recent advances in therapy. R Champlin RP Gale, Blood 1987 69 1551 1562 3555647 (Pubitemid 17091605)
2. Bone marrow transplants may cure patients with acute leukemia never achieving remission with chemotherapy. JC Biggs MM Horowitz RP Gale RC Ash K Atkinson W Helbig N Jacobsen GL Phillips AA Rimm O Ringdén,, et al. Blood 1992 80 1090 1093 1498326
3. Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell dose. J Sierra B Storer JA Hansen JW Bjerke PJ Martin EW Petersdorf FR Appelbaum E Bryant TR Chauncey G Sale,, et al. Blood 1997 89 4226 4235 9166868 (Pubitemid 27220974)
4. Leukemia-free survival and mortality in patients with refractory or relapsed acute leukemia given marrow transplants from sibling and unrelated donors. HT Greinix E Reiter F Keil G Fischer K Lechner K Dieckmann G Leitner A Schulenburg P Hoecker OA Haas,, et al. Bone Marrow Transplant 1998 21 673 678 10.1038/sj.bmt.1701152 9578306 (Pubitemid 28159603)
5. Prognostic factors for outcomes of patients with refractory or relapsed acute myelogenous leukemia or myelodysplastic syndromes undergoing allogeneic progenitor cell transplantation. R Wong M Shahjahan X Wang PF Thall M De Lima I Khouri J Gajewski J Alamo D Couriel BS Andersson,, et al. Biol Blood Marrow Transplant 2005 11 108 114 10.1016/j.bbmt.2004.10.008 15682071 (Pubitemid 40186207)
6. Allogeneic stem-cell transplantation in patients with refractory acute leukemia: a long-term follow-up. AA Oyekunle N Kröger T Zabelina F Ayuk H Schieder H Renges N Fehse O Waschke B Fehse H Kabisch,, et al. Bone Marrow Transplant 2006 37 45 50 16258531 (Pubitemid 43135314)
7. High-dose etoposide, cyclophosphamide, and total body irradiation with allogeneic bone marrow transplantation for patients with acute myeloid leukemia in untreated first relapse: a study by the North American Marrow Transplant Group. RA Brown SN Wolff JW Fay L Pineiro RH Collins Jr JP Lynch D Stevens J Greer RH Herzig GP Herzig, Blood 1995 85 1391 1395 7858269
8. High-dose etoposide, cyclophosphamide and total body irradiation with allogeneic bone marrow transplantation for resistant acute myeloid leukemia: a study by the North American Marrow Transplant Group. RA Brown SN Wolff JW Fay L Pineiro RH Collins Jr JP Lynch D Stevens J Greer RH Herzig GP Herzig, Leuk Lymphoma 1996 22 271 277 10.3109/10428199609051758 8819076 (Pubitemid 26318716)
9. Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure. M Duval JP Klein W He JY Cahn M Cairo BM Camitta R Kamble E Copelan M de Lima V Gupta,, et al. J Clin Oncol 2010 28 3730 3738 10.1200/JCO.2010.28.8852 20625136
10. Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study. ML Slovak KJ Kopecky PA Cassileth DH Harrington KS Theil A Mohamed E Paietta CL Willman DR Head JM Rowe,, et al. Blood 2000 96 4075 4083 11110676
11. Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial. AV Moorman CJ Harrison GA Buck SM Richards LM Secker-Walker M Martineau GH Vance AM Cherry RR Higgins AK Fielding,, et al. Blood 2007 109 3189 3197 10.1182/blood-2006-10-051912 17170120 (Pubitemid 46572503)
12. -1994 Consensus Conference on Acute GVHD Grading. D Przepiorka D Weisdorf P Martin HG Klingemann P Beatty J Hows ED Thomas, Bone Marrow Transplant 1995 15 825 828 7581076
13. How I treat chronic graft-versus-host disease. GB Vogelsang, Blood 2001 97 1196 1201 10.1182/blood.V97.5.1196 11222360 (Pubitemid 32183739)
14. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. TA Gooley W Leisenring J Crowley BE Storer, Stat Med 1999 18 695 706 10.1002/(SICI)1097-0258(19990330)18:6<695:: AID-SIM603.0.CO;2-O 10204198 (Pubitemid 29126745)
15. Statistical considerations in studies of late effects in HCT. BE Storer, Biol Blood Marrow Transplant 2009 15 Suppl 1 25 28 10.1016/j.bbmt.2008.10.003 19147073
16. Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. F Baron MB Maris BM Sandmaier BE Storer M Sorror R Diaconescu AE Woolfrey TR Chauncey ME Flowers M Mielcarek,, et al. J Clin Oncol 2005 23 1993 2003 10.1200/JCO.2005.08.136 15774790 (Pubitemid 46211379)
17. Long-term survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem cell transplantation. C Schmid M Schleuning R Schwerdtfeger B Hertenstein E Mischak-Weissinger D Bunjes SV Harsdorf C Scheid U Holtick H Greinix, Blood 2006 108 1092 1099 10.1182/blood-2005-10-4165 16551971 (Pubitemid 44154650)